首页|纤维介素2在卵巢癌中的表达及其对SKOV3细胞生物学特性的影响

纤维介素2在卵巢癌中的表达及其对SKOV3细胞生物学特性的影响

扫码查看
目的 探讨纤维介素2(FGL2)在上皮性卵巢癌中的表达情况及其对人卵巢癌SK-OV3细胞生物学特性的影响及相关机制.方法 ①取2018年7月-2020年5月在河北省人民医院行手术治疗的40例浆液性卵巢癌以及16例卵巢浆液性囊腺瘤患者的切除组织标本,免疫组化法检测组织标本中FGL2蛋白表达情况.②取SKOV3细胞,实验设空白组、FGL2 siRNA转染组和阴性对照siRNA组,采用Western blot法检测细胞中FGL2蛋白表达情况,以确定FGL2 siRNA转染效率;后续通过CCK-8法以及Transwell实验检测FGL2 siRNA转染组和阴性对照siRNA组SK-OV3细胞增殖、侵袭及迁移能力,Western blot法检测细胞中白细胞介素-6(IL-6)、信号转导和转录激活因子3(STAT3)蛋白表达情况,观察沉默FGL2对SKOV3细胞增殖、侵袭及迁移能力和IL-6/STAT3信号通路的影响.结果 浆液性卵巢癌患者组织标本中FGL2蛋白高表达率明显高于卵巢浆液性囊腺瘤患者[80.0%(32/40)比 37.5%(6/16),P<0.05].FGL2 siRNA 转染组 FGL2 蛋白相对表达量明显低于阴性对照siRNA组(P<0.05);FGL2 siRNA转染组转染后48 h、72 h、96 h、120 h的SKOV3细胞增殖活性均明显低于同期阴性对照siRNA组(P均<0.05);Transwell加基质胶侵袭实验和不加基质胶迁移实验显示FGL2 siRNA转染组穿膜细胞数均明显少于阴性对照siR-NA 组(P均<0.05);FGL2 siRNA组IL-6和p-STAT3蛋白相对表达量均明显低于阴性对照siR-NA组(P均<0.05).结论 卵巢癌组织中存在FGL2高表达,沉默FGL2抑制IL-6/STAT3信号通路的活性可影响卵巢癌细胞的生物学特性,推测FGL2可作为卵巢癌诊治的靶点之一.
Expression of fibronectin 2 in ovarian cancer and its impact on the biological characteristics of SKOV3 cells
Objective It is to explore the expression of fibronectin 2(FGL2)in epithelial ovarian cancer,and to study its effect on the biological characteristics of human ovarian cancer SKOV3 cells and correlated mechanisms.Methods ①The resected tissue specimens were taken from 40 cases of patients with serous ovarian carcinoma and 16 cases of patients with serous cystadenoma of ovary who underwent surgical treatment in Hebei General Hospital,and the expression of FGL2 protein in the tissue specimens was detected by immunohistochemistry.②The SKOV3 cells were taken and divided into FGL2 siRNA transfection group and negative control siRNA group,the FGL2 protein expression in the cells was detected by Western blot to determine the efficiency of FGL2 siRNA transfection,then the proliferation,invasion and migration ability of SKOV3 cells in the FGL2 siRNA transfection group and negative control siRNA group were subsequently detected by CCK-8 assay and Transwell assay,and the protein expressions of interleukin-6(IL-6),signal transducer and activator of transcription 3(STAT3)in the cells were detected by Western blot assay,so as to observe the effect of silencing of FGL2 on the proliferation,invasion and migration ability of SKOV3 cells and on IL-6/STAT3 signaling pathway.Results The high expression rate of FGL2 protein in tissue specimens from patients with serous ovarian carcinoma was significantly higher than that from patients with serous cystadenoma of ovary[80.0%(32/40)versus 37.5%(6/16),P<0.05].The rela-tive expression of FGL2 protein in the FGL2 siRNA-transfection group was significantly lower than that of the negative con-trol siRNA group(P<0.05);the proliferative activity of SKOV3 cells at 48 h,72 h,96 h and 120 h after transfection in the FGL2 siRNA-transfection group was significantly lower than that of the negative control siRNA group(P<0.05);Tran-swell invasion assay with matrix gel and migration assay without matrix gel showed that the number of membrane-penetrating cells in the FGL2 siRNA transfection group was significantly less than that in the negative control siRNA group(P<0.05);the relative expression of 1L-6 and p-STAT3 proteins in the FGL2 siRNA group were both significantly lower than those in the negative control siRNA group(both P<0.05).Conclusion There is high FGL2 expression in ovarian cancer tissues,silencing FGL2 to inhibit the activity of IL-6/STAT3 signaling pathway can inflence the biological characteristics of ovarian epithelial cancer cells,which suggests that FGL2 may serve as one of the potential targets for the diagnosis and treatment of ovarian cancer.

ovarian carcinomaFGL2invasionmigrationinterleukin-6signal transducer and activator of transcrip-tion 3

王新玲、李楠、赵武杰、王斌、王雅卓、范静、李娜

展开 >

河北省人民医院,河北石家庄 050051

河北医科大学,河北石家庄 050011

卵巢癌 纤维介素2 侵袭 迁移 白细胞介素-6 信号转导和转录激活因子3

河北省卫健委重点科技研究计划项目

20170292

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(12)
  • 4